Eemergence of promising therapies in diabetes mellitus
S Akkati, KG Sam, G Tungha - The Journal of Clinical …, 2011 - Wiley Online Library
Diabetes mellitus (DM) results from defects in insulin secretion (type 1) or insulin resistance
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
Emergence of promising therapies in diabetes mellitus.
S Akkati, KG Sam, G Tungha - Journal of Clinical Pharmacology, 2010 - europepmc.org
Diabetes mellitus (DM) results from defects in insulin secretion (type 1) or insulin resistance
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
Emergence of promising therapies in diabetes mellitus
S Akkati, KG Sam, G Tungha - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Diabetes mellitus (DM) results from defects in insulin secretion (type 1) or insulin resistance
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
(type 2). Insulin is used to manage type 1 DM, and oral hypoglycemic agents are used to …
[引用][C] Eemergence of Promising Therapies in Diabetes Mellitus
S Akkati, KG Sam, G Tungha - The Journal of Clinical Pharmacology, 2011 - cir.nii.ac.jp
Eemergence of Promising Therapies in Diabetes Mellitus | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …